22nd Century Gross Margin 2012-2026 | XXII

Current and historical gross margin for 22nd Century (XXII) over the last 10 years. The current gross profit margin for 22nd Century as of March 31, 2026 is %.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
22nd Century Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2026-03-31 $0.02B $0.00B -25.00%
2025-12-31 $0.02B $0.00B -22.22%
2025-09-30 $0.02B $0.00B -22.22%
2025-06-30 $0.02B $0.00B -20.00%
2025-03-31 $0.02B $0.00B -8.33%
2024-12-31 $0.02B $0.00B -8.33%
2024-09-30 $0.03B $-0.01B -33.33%
2024-06-30 $0.03B $-0.01B -27.59%
2024-03-31 $0.03B $-0.01B -34.48%
2023-12-31 $0.03B $-0.01B -28.13%
2023-09-30 $0.02B $0.00B -4.35%
2023-06-30 $0.03B 0 0.00%
2023-03-31 $0.04B $0.00B 5.00%
2022-12-31 $0.04B $0.00B 5.00%
2022-09-30 $0.05B $0.00B 4.00%
2022-06-30 $0.04B $0.00B 2.56%
2022-03-31 $0.03B 0 0.00%
2021-12-31 $0.03B $0.00B 3.23%
2021-09-30 $0.03B $0.00B 6.67%
2021-06-30 $0.03B $0.00B 6.90%
2021-03-31 $0.03B $0.00B 7.41%
2020-12-31 $0.03B $0.00B 3.70%
2020-09-30 $0.03B 0 0.00%
2020-06-30 $0.03B 0 0.00%
2020-03-31 $0.03B 0 0.00%
2019-12-31 $0.03B 0 0.00%
2019-09-30 $0.03B $0.00B 4.00%
2019-06-30 $0.03B $0.00B 4.00%
2019-03-31 $0.03B $0.00B 3.85%
2018-12-31 $0.03B $0.00B 3.85%
2018-09-30 $0.03B 0 0.00%
2018-06-30 $0.02B 0 0.00%
2018-03-31 $0.02B 0 0.00%
2017-12-31 $0.02B 0 0.00%
2017-09-30 $0.01B 0 0.00%
2017-06-30 $0.01B 0 0.00%
2017-03-31 $0.01B 0 0.00%
2016-12-31 $0.01B 0 0.00%
2016-09-30 $0.01B 0 0.00%
2016-06-30 $0.01B 0 0.00%
2016-03-31 $0.01B 0 0.00%
2015-12-31 $0.01B 0 0.00%
2015-09-30 $0.01B 0 0.00%
2015-06-30 $0.00B 0 0.00%
2015-03-31 $0.00B 0 0.00%
2014-12-31 $0.00B 0 0.00%
2014-09-30 $0.01B $0.01B 100.00%
2014-06-30 $0.01B $0.01B 100.00%
2013-09-30 $0.00B 0 0.00%
2012-09-30 $0.00B 0 0.00%
2011-12-31 $0.00B 0 0.00%
Sector Industry Market Cap Revenue
Consumer Staples Tobacco Products $0.001B $0.018B
22nd Century Group, Inc. is a plant biotechnology company focused on decreasing/increasing the level of nicotine in the tobacco plant through genetic engineering and breeding. The Company is focused on development of smoking cessation aid and owns and controls several patents. The company's products include X-22, a prescription smoking cessation aid, which is a tobacco-based botanical medical product for use as a smoking cessation therapy. 22nd Century Group, Inc. is based in Williamsville, New York.
Stock Name Country Market Cap PE Ratio
Philip Morris (PM) United States $250.066B 21.28
British American Tobacco (BTI) United Kingdom $120.087B 0.00
Altria (MO) United States $112.613B 12.43
JAPAN TOB (JAPAY) Japan $66.869B 20.69
Imperial Tobacco Group (IMBBY) United Kingdom $32.506B 0.00
Turning Point Brands (TPB) United States $1.616B 26.70
Universal (UVV) United States $1.332B 13.73
Ispire Technology (ISPR) United States $0.100B 0.00
Charlie's Holdings (CHUC) United States $0.066B 24.20